B/27. General properties of NSAIDs. Acetylsalicylic acid. Flashcards
Drugs need to know in this topic
acetylsalicylsav
colchicin
allopurinol
rasburicase
acetylsalicylic acid
- Irreversible inhibition of COX enzymes (acetylation of
serine hydroxyl group) - Oral
- Low doses → first order elimination, T1/2 3-5 h’
- High doses → zero-order elimination, T1/2 up to 15 h’
- Renal elimination
- *Dose-dependent effects:**
1. Low dose (< 300 mg/d):
1. anti-platelet aggregation effect (post MI prophylaxis, reduce the risk of CV events)
2. Medium dose (300-2400 mg/d): analgesic and anti-pyretic effects
3. High dose (2400-5000 mg/d): anti-inflammatory effects
Side effects
∙Gastric bowel ulcers :↓PG level+local destroying effect
∙Decreased renal function, water retention :↓RBF, accumulation of NSAIDs
∙Cartilage damage: ↓PG level ->higher ROS level
∙Ductus Botallo closure : COX1 inh are CI in the 3rd trimester
∙Decrease of uterus contractility: prolonged delivery, increased bleeding
∙Pseudoallergic reaction: rash, bronchoconstriction
∙Cardiotoxicity: proarrythmic effects
Colchicine
Microtubule assembly inhibitors
Bind to tubulin → altered microtubular polymerization, LTB4 ↓, altered leukocyte and granulocyte migration
Oral, parentera
- Acute gout – high doses required (use is limited due to severe diarrhea)
- Chronic gout – low doses
- Familial Mediterranean fever
- Potential role in the management of pericardial diseases (pericarditis, pericardial effusion)
Side effects:
- Acute: severe diarrhea, GI pain
- Longer use: hematuria, alopecia, myelosuppression, gastritis, peripheral neuropathy
Allopurinol
Xanthine oxidase inhibitors
Inhibit xanthine oxidase → decreased purine metabolism → serum uric acid ↓
- Oral
- Prodrug, activated by xanthine oxidase
- At high doses, active metabolite acts as a ‘suicide inhibitor’
(irreversible inhibition) - Drug interaction → inhibit metabolism of 6-MP
- Chronic gout
- Adjunct to cancer chemotherapy and radiotherapy (‘tumor-lysis
syndrome’ – may precipitate gout attack)
Side effects: - GI irritation
- Hypersensitivity reaction, Stevens-Johnson syndrome
- Bone marrow suppression
Rasburicase
Recombinant urate oxidase
Urate oxidase enzyme catalyzes the metabolism of uric acid to allantoin (water-soluble) → serum uric acid ↓, uric acid precipitation ↓
- IV
- T1/2 up to 18 h’